Abstract: Introduction: The global impact of 2020 due to the COVID-19 pandemic will be a large global decline in TB in terms of the number of people newly diagnosed with TB. The gap is due to being underdiagnosed with TB because the person does not have access to health care or is not diagnosed correctly. The diagnosis of TB cases in Indonesia is still on microscopic examination of sputum which has a low accuracy value, while the culture of sputum takes a long time. One alternative option is the lipoarabinomannan (LAM) urine antigen test. The literature review was compiled to determine the effectiveness of the lipoarabinomannan (LAM) urine antigen test in establishing the diagnosis of pulmonary TB.